STORE   |   Contact Us   |   Sign In   |   Become Member
News & Press: SIT Newsletter

SIT Newsletter: March 2020

Tuesday, February 25, 2020  
Share |

SCHOLAR IN TRAINING NEWSLETTER
   

NOW OPEN
Particle Radiobiology in Space & Oncology Symposium Registration

MARCH 30
Abstract Submission Closes for Annual Meeting
Learn More



NEW RRS CAREER CENTER!
View job postings, submit a resume and access career resources.
VIEW POSITIONS

Postdoctoral Position- Radiation Biology/Metabolism
Georgetown University Medical Center
Washington, DC
More Information

Postdoctoral Fellow- Immune/DNA Repair Response
Sawakuchi and Shaitelman Lab
Houston, TX
More Information

Cancer Discipline Scientist
NASA
Houston, TX
More Information

Data Sciences/Chemistry Data Curator/Bioinformatics
Rancho Biosciences
San Diego, CA
More Information

Various Positions
IAEA at Argonne National Laboratory
More Information

Postdoctoral Fellow- Open Positions
Rice University Dept. of Bioengineering
Houston, TX
More Information

Postdoctoral Fellow- Open Positions
University of Texas
San Antonio, TX
More Information

Curriculum Fellow for Online Learning- Immunology
Harvard Medical School
Boston, MA
More Information

Scientist- Molecular Biology
10X Genomics
Pleasanton, CA
More Information

Postdoctoral Fellow
University of Texas at MD Anderson Cancer Center
Houston, TX
More Information

Assistant Professor (tenure-track)
Rutgers University, New Jersey Medical School
Newark, NJ
More Information

Postdoctoral Position- Molecular Imaging and Therapy
University of California
San Francisco, CA
More Information

Postdoctoral Position- Radiation Oncology
University of California
San Francisco, CA
More Information


FOR MORE CAREER POSTINGS, VISIT:

www.academicjobs.org 
www.researchgate.net/jobs
www.findaphd.com 

2019
RRS Workshop: Challenges & Solutions in the Era of Targeted Radionuclide-Based Therapy
Big Sky Resort, MT
March 4-6, 2020
Registration Open!
GET INFO


NCRP Annual Meeting
Bethesda, MD
March 23-24, 2020
GET INFO

AACR Annual Meeting: Turning Science into Lifesaving Care
San Diego, CA
April 24-29, 2020
GET INFO

1st International Workshop on Radiobiology of Molecular Radiotherapy

Montpellier, France
May 13-14, 2020
GET INFO

Particle Radiobiology in Space & Oncology - RRS and affiliates
Bethesda, MD
May 27-29, 2020
GET INFO

ImmunoRad - International Conference on Immunotherapy-Radiotherapy Combination
Paris, France
September 23-25, 2020
GET INFO

RRS Annual Meeting
Big Island, HI
October 18-21, 2020
GET INFO
CHAIR
Jason Domogauer- Medicine
COMMITTEE MEMBERS
Jade Moore- Medicine/Biology
Britta Langen- Biology
Brian Canter- Biology
Julie Constanzo- BioPhysics
Calvin Leung- Medicine/Biology
Rutul Patel- Pharmacology
Alexandra Taraboletti-Biology
Tien Tang- Biology
Frederico Kiffer: Neurobiology
Caitlin Milder: Epidemiology
Nicole Chmielewski-Stivers: Oncology
Lydia Wilson: Medicine/Physics

Dear SIT Members,

Raise your hand, please, if you have written a grant application!
Now lower your hand if you could select radiobiology as a submission category.

Those of you who still have their hands up–what did you do about it?

Surely, you selected the descriptor closest to your research topic; maybe radiation therapy or something biologically related such as signal transduction? At least, that’s what I did when I applied for the European Marie Skłodowska-Curie Actions (MSCA). The descriptor in this application is even highlighted by the funding body ‘to be chosen with great care’, since it acts as a key mechanism in the review process for selecting appropriate referees.

So when choosing a placeholder descriptor, I had to make a critical choice: would the application be more favorably reviewed by clinical experts (e.g. oncologists or medical physicists), or by researchers (e.g. immunologists or biologists)? One would have excellent knowledge of the radiation aspect, the other of hardcore biology; but neither would be fully equipped to evaluate a synergy project.

When I received the grant reviews (spoiler: rejected), I felt at least validated in my worry about a surrogate descriptor. Although some designated weaknesses were valid, some showed lack of familiarity with radiobiology. For a moment, I indulged myself and wondered if my grant life would be easier if I worked in an ‘unambiguous’ field such as cancer research… But why wonder? Thanks to our not-so-new Policy and Advocacy section, I became inspired to get active. As luck would have it, I have a friend who works at the German Federal Ministry of Education and Research (BMBF). I told him about my dilemma and learned about the National Contact Points within the Horizon 2020 framework–and that they also act as a help desk for precisely such issues. So I did just that: wrote an email, described the dilemma, and kindly asked to include radiobiology in the list of descriptors.

As of now, I cannot tell you how this little political quest ends–I am still waiting on a reply. But I wanted to share with you that Advocacy issues occur more frequently than we might think–and we, as young researchers, are precisely the people to do something about them.

Sincerely,
Britta Langen
SIT Committee Member

We are also on Facebook! Check out the SIT Facebook group.
 
REGISTER NOW: RRS SYMPOSIUM WITH NCI & NASA
The 3-day Joint Symposium, “Particle Radiobiology in Space and Oncology,” will be held May 27-29, 2020 in coordination with other Federal Government Agencies/Institutes that have active programs in radiation research.

Over 50 pre-eminent experts will compare and contrast the needs in radiobiology for space exploration and radiation oncology. Over 12 fast-track sessions, topics of mutual interest from the perspectives of space, research, and the clinic will be discussed to facilitate opportunities to synergistically enhance & maximize efforts across the many fields of the radiation sciences. This collaborative symposium represents a unique program arranged between RRS, NCI & NASA, in addition to several other Federal Agencies.

We hope you will join us for a refreshing & purposeful approach to solve future challenges facing the radiation sciences community. See how our similarities and differences become an opportunity for growth when approached collectively.


LEARN MORE | REGISTER
 
POLICY AND ADVOCACY
In the United States, the media has extensively covered the spread of COVID-19, an illness caused by the SARS-CoV-2 coronavirus originating in Wuhan, China. I was fascinated by the difference between how the media reported on the pandemic versus the dialogue on social media and online speculation. This piece by Alexis Madrigal absolutely captivated me. She details how a Harvard-affiliated epidemiologist spread preliminary and non-peer reviewed science without proper context.

The epidemiologist was not a subject matter expert in virology or pandemics but that did not stop him from instilling fear. While his follower count on Twitter increased from 2000 to over 85000 so did panic over the R0 value for COVID-19. R0 represents the average number of people that will be infected by one infected individual. While this number is useful for epidemiologists, policymakers and others helping to fight the disease outbreak, it is not as helpful for communicating risk to the public.

Ultimately subject matter experts in the spread of infectious diseases stepped in to confront this misinformation online. Yet the misinformation problem remains an uphill battle. I see the current spread of misinformation on SARS-CoV-2 as being emblematic of two larger issues. The first issue is the innate desire one has for more information on breaking news. That issue requires us all to accept we cannot have the most up to date information right away despite our technological advances. The second issue is one of public trust in institutions like the media and academia. When the public loses trust in the gatekeepers of truth, the public begins to search for information from unvetted sources.

As radiation researchers, I believe it's our responsibility to work in the public’s interest in providing the most accurate information on how the public can protect themselves from the harm of ionizing radiation. This sentiment closely matches one of the missions of the National Council on Radiation Protection and Measurements (NCRP-M). We all do not serve on the NCRP-M but we have a network full of NCRP-M members and those who work with NCRP-M members. Working to earn the public’s trust will assist our community in guiding the public when there is an event that elicits fear of exposure to ionizing radiation.

If you want a particular topic or issue addressed in this section, please feel free to reach out to me via email at brian.canter@rutgers.edu!

Brian Canter
SIT Committee Member

SIT FEATURE OF THE MONTH
This month, we have the pleasure to feature Lydia Wilson – one of our new SIT committee members:

I'm a postdoctoral researcher in the Department of Radiation Oncology at St. Jude Children's Research Hospital and plan to pursue a career as a medical physics professor and independent investigator. I originally pursued radiation research via medical physics because I saw in it the perfect opportunity to combine my love for the analytical problem solving of physics with my desire to more directly help people. I'm a hopeless combination of empathetic and curious, which drives me to endlessly pursue more accurate diagnostic tools, more effective treatments, and more holistic approaches to follow-up care, all of which radiation research touches. In general, I hope that my research will help guide the field of radiation research to a deeper understanding of the link between the complex physics of radiation exposures (medical and otherwise) and their biologic effects. My goal is to leverage this deeper understanding to improve the quality of life of long-term survivors of cancer through safer and more effective radiation treatments.




 
 
 
RECENT SIT PUBLICATIONS
Leung CN, Canter BS, Rajon D, Bäck TA, Fritton JC, Azzam EI, Howell RW. Dose-dependent growth delay of breast cancer xenografts in the bone marrow of mice treated with 223Ra: the role of bystander effects and their potential for therapy. Journal of Nuclear Medicine. 2020 Jan;61(1):89–95.

Do you know of any SIT publications? Please let us know!
 
FUNDING RESOURCES
Thrasher Research Fund
Application Deadline: March 17, 2020

Women In Aerospace Foundation Scholarship
Application Deadline: June 16, 20202


France-Stanford Center for Interdisciplinary Studies

Application Deadline: March 2021

Burroughs Wellcome Awards
Application Deadline: Open

Engineering & Physical Sciences Research Council

Application Deadline: Open

Alexander von Humboldt-Stiftung/Foundation
Application Deadline: Open

Burrows Wellcome Fund
Application Deadline: Open
 
Antibodies Travel Grants Program
Application Deadline: Quarterly
 
ASTRO Funding Opportunities
ASTRO funds research in radiation biology, cancer biology and radiation physics. Funding opportunities are available for junior faculty and residents.

Proposal Central
Database of foundation, non-profits and organizations grants.
 
Do you know of any other funding sources? Please let us know! 
RADIATION RESEARCH SOCIETY 
Audrey Rinehart, Association Manager 
380 Ice Center Lane, Suite C | Bozeman, MT 59718 
1.877.216.1919 | audrey@radres.org
Follow us on Twitter
   
Twitter
View our profile on LinkedIn
LinkedIn
Like us on Facebook
Facebook
Like us on Facebook
SIT Group
View our videos on YouTube
YouTube
View our photos on flickr
Flickr
Click icon to connect!

Membership Management Software Powered by YourMembership  ::  Legal